Newswise – Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine’s Game Changer Vehicles, Bringing Free Health Education and Screening for Many Cancers to Needy South Florida Communities, Offer Antigen for the First Time prostate specific (PSA) screening for prostate cancer.
“When we get prostate cancer in the early stages, there is a 95% chance that we can cure it. But when you get prostate cancer when it has spread beyond the prostate, there’s only a 25% to 30% chance of survival at five years, “said Brandon Mahal, MD, assistant professor of radiation oncology at Sylvester. “PSA is the best screening test we have in terms of being able to get cancer early and being able to cure it.”
According to Dr. mahal.
PSA is a simple blood test. Men who get their PSA screenings on Game Changer will usually have their results within 24 hours. There will be no charge for Game Changer PSA screenings, and those whose results indicate further treatment will be advised and directed to places where they will have access to treatment, said Dr. Mahal said.
“The Sylvester Office of Outreach and Engagement team and the Game Changer program have been providing cancer prevention and screening services to the South Florida community for several years,” said Paco C. Castellon, MPH, MBA, program director of engagement and awareness of the Sylvester community. “A key component of our program since its inception has been our ongoing two-way engagement with community stakeholders to understand the needs of the South Florida community. It was through this ongoing engagement with the community that we learned of the community’s interest in prostate cancer screening.
“This initiative, which is a collaboration between the Sylvester Comprehensive Cancer Center, organizations represented in the Southeast Florida Cancer Control Collaborative, and ZERO – The End of Prostate Cancer, underscores the importance of strong community-academic partnerships in addressing the needs of community, with the aim of achieving health equity, “Castellon said.
ZERO – The End of Prostate Cancer is a national non-profit organization with a mission to end prostate cancer and help those affected.
“We are partnering with Sylvester on the Game Changer Prostate Cancer Screening Program because our mission is to create solutions to achieve health equity to meet the community’s most critical needs,” said Reggie Tucker Seeley, Sc.D., Vice President Health Equity to ZERO – The End of Prostate Cancer. This program helps address prostate cancer disparities by raising awareness of prostate cancer through our educational materials and resources, providing free PSA screenings through Game Changer vehicles, and connecting men to Sylvester if they need follow-up care. after screening. “
Sylvester’s mobile PSA screening program is one of only two in the United States that Dr. Mahal is aware of. The other started this year at Mount Sinai in New York City.
Sylvester has also partnered with the Southeast Florida Cancer Control Collaborative (SFCCC), a volunteer organization made up of representatives from health care groups, community organizations, advocacy groups, and others interested in cancer control networking and education at Broward, Indian River counties of, Martin, Miami-Dade, Monroe, Okeechobee, Palm Beach and St. Lucie.
“We cannot control prostate cancer in Southeast Florida without addressing the disparities that exist in its detection,” said Pascale Auguste, who leads the SFCCC’s inequality working group. “By incorporating PSA screening on Game Changer vehicles, Sylvester will help increase the availability of prostate cancer screening in strategically selected locations and provide culturally appropriate education, both of which are key to addressing racial disparities in prostate cancer detection in black men. “
PSA education is essential
PSA screening recommendations have changed over the years and many don’t know if or when PSA should be done.
“Recent research has suggested that a decrease in prostate cancer screening has led to an increased incidence of men diagnosed with metastatic and incurable diseases,” said Sanoj Punnen, MD, MAS, Pap Corps Champions for Cancer Research Endowed Chair in Solid Tumor Research, associate professor and vice president of research, Desai Sethi Urology Institute, and co-chair of the Genitourinary Site Disease Group in Sylvester. “The Game Changer will allow us to submit this valuable screening test to the populations most at risk.”
Historically there has been some controversy over PSA, according to Dr. mahal.
“Specifically in 2012, the United States Preventive Services Task Force (USPSTF) presented a recommendation against PSA screening, a grade D recommendation, because two screening studies came out, one in the United States and one in Europe, and showed at the time that the number of men needed to screen with PSA screening to save a man’s life was over 1,000, ”said Dr. Mahal.
The USPSTF said having to screen so many men to save a life decreased the value of the test.
“The problem with this, and what many prostate cancer experts were warning the task force about, was that prostate cancer takes a long time to become a problem. They based the initial recommendation on just seven years of follow-up on the PSA studies, ”said Dr Mahal said.
Additionally, the task force – which had no prostate cancer experts – was concerned about overtreatment, but underestimated the number of men who can be safely observed in an active monitoring program called active surveillance, thus avoiding overtreatment and the adverse effects in relation to it, according to Dr. points.
The USPSTF changed positions in 2018, after 13 years of follow-up they showed that fewer than 800 men needed to be screened to save a man’s life.
Today, the task force no longer recommends PSA screening but leaves the decision to the doctor and patient, according to Dr. mahal.
“Nearly all major cancer organizations, including the American Cancer Society, the American Society of Clinical Oncology (ASCO), the Prostate Cancer Foundation, and the American Urological Association, recommend PSA screening predominantly for men aged between 50 and 70 years, with the precise age range varying according to the organization making the recommendations, “said Dr. Mahal said. “These organizations also agree that high-risk men should probably start screening around age 45. So, on Game Changer vehicles, we will target high-risk men between the ages of 45 and 69.”
Sylvester’s Game Changer PSA program attracted the attention of principal investigator of the STAMPEDE study in prostate cancer, Nicholas James, MBBS, FRCP, FRCR, Ph.D., professor of clinical oncology at the Institute of Cancer Research at the Royal Marsden Hospital in London.
“We are collaborating with Dr. James and colleagues to develop a point-of-care PSA test on the mobile clinic, where we would have results immediately. This has never been done before and it is only at the beginning, ‘said Dr mahal.
The Game Changer vehicle offered prostate cancer screening service on September 10 at La Respectable Loge in Miami and on September 13 at the Center for Haitian Studies in Miami. The Game Changer will offer the service on Friday, September 23, from 9am to 1pm, at a back to school community event in Liberty City at 6304 NW 14th Avenue, Miami, Florida 33147.
For more information on upcoming screenings, click here. If you have any questions about the Game Changer, please contact us [email protected]